NEUROCRINE BIOSCIENCES INC
Total Trades
200
Buys
0
Sells
145
Largest Trade
N/A
Insiders
17
Institutional Funds
622
Inst. Value
$1M+
Activist Filings
13
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Gano Kyle | CEO | SELL | $1M+ | 36K | $132.70 | Jan 20, 2026 |
| Gano Kyle | CEO | EXERCISE | $1M+ | 36K | $35.99 | Jan 20, 2026 |
| Norwalk Leslie V | Director | EXERCISE | $500K+ | 10K | $91.07 | Dec 17, 2025 |
| Norwalk Leslie V | Director | SELL | $500K+ | 6K | $152.78 | Dec 17, 2025 |
| Lippoldt Darin | Chief Legal Officer | EXERCISE | $100K–$500K | 4K | $43.24 | Dec 10, 2025 |
| Lippoldt Darin | Chief Legal Officer | SELL | $500K+ | 4K | $159.65 | Dec 10, 2025 |
| LYONS GARY A | Director | SELL | $1M+ | 15K | $152.61 | Dec 4, 2025 |
| LYONS GARY A | Director | EXERCISE | $500K+ | 15K | $47.89 | Dec 4, 2025 |
| BENEVICH ERIC | Chief Commercial O… | EXERCISE | $100K–$500K | 6K | $35.99 | Dec 2, 2025 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $500K+ | 6K | $151.74 | Dec 2, 2025 |
| MORROW GEORGE J | Director | EXERCISE | $500K+ | 15K | $47.89 | Nov 26, 2025 |
| MORROW GEORGE J | Director | SELL | $1M+ | 15K | $143.37 | Nov 26, 2025 |
| RASTETTER WILLIAM H | Director | SELL | $1M+ | 18K | $151.82 | Nov 6, 2025 |
| RASTETTER WILLIAM H | Director | EXERCISE | $500K+ | 18K | $47.89 | Nov 6, 2025 |
| Gano Kyle | CEO | EXERCISE | N/A | 613 | — | Nov 5, 2025 |
| Gano Kyle | CEO | SELL | $15K–$50K | 300 | $141.97 | Nov 5, 2025 |
| Delaet Ingrid | Chief Regulatory O… | SELL | $50K–$100K | 457 | $135.00 | Jul 11, 2025 |
| Delaet Ingrid | Chief Regulatory O… | EXERCISE | $15K–$50K | 457 | $79.02 | Jul 11, 2025 |
| Onyia Jude | Chief Scientific O… | EXERCISE | $1M+ | 60K | $84.74 | Jul 11, 2025 |
| Onyia Jude | Chief Scientific O… | SELL | $1M+ | 60K | $130.46 | Jul 11, 2025 |
| Onyia Jude | Chief Scientific O… | EXERCISE | $1M+ | 20K | $84.74 | Jul 7, 2025 |
| Onyia Jude | Chief Scientific O… | SELL | $1M+ | 20K | $130.13 | Jul 7, 2025 |
| GORMAN KEVIN CHARLES | Director | SELL | $1M+ | 10K | $120.38 | May 29, 2025 |
| RASTETTER WILLIAM H | Director | EXERCISE | $1M+ | 30K | $42.76 | May 7, 2025 |
| RASTETTER WILLIAM H | Director | SELL | $1M+ | 30K | $110.20 | May 7, 2025 |
| GORMAN KEVIN CHARLES | Director | EXERCISE | $1M+ | 146K | $32.99 | Jan 30, 2025 |
| GORMAN KEVIN CHARLES | Director | SELL | $1M+ | 146K | $149.46 | Jan 30, 2025 |
| Gano Kyle | CEO | EXERCISE | $1M+ | 65K | $32.99 | Jan 17, 2025 |
| Gano Kyle | CEO | SELL | $1M+ | 65K | $141.50 | Jan 17, 2025 |
| Delaet Ingrid | Chief Regulatory O… | EXERCISE | $15K–$50K | 272 | $79.02 | Jan 3, 2025 |
| Delaet Ingrid | Chief Regulatory O… | SELL | $15K–$50K | 272 | $138.10 | Jan 3, 2025 |
| Onyia Jude | Chief Scientific O… | EXERCISE | N/A | 4K | — | Dec 3, 2024 |
| Onyia Jude | Chief Scientific O… | SELL | $100K–$500K | 2K | $126.29 | Dec 3, 2024 |
| Boyer David W. | Chief Corp. Affair… | SELL | $100K–$500K | 1K | $113.66 | Oct 7, 2024 |
| RASTETTER WILLIAM H | Director | SELL | $1M+ | 14K | $146.69 | Aug 16, 2024 |
| Cooke Julie | CHRO | SELL | $1M+ | 10K | $140.19 | Jul 3, 2024 |
| Cooke Julie | CHRO | EXERCISE | $500K+ | 10K | $61.82 | Jul 3, 2024 |
| Delaet Ingrid | Chief Regulatory O… | EXERCISE | $15K–$50K | 272 | $79.02 | Jul 3, 2024 |
| Delaet Ingrid | Chief Regulatory O… | SELL | $15K–$50K | 272 | $138.11 | Jul 3, 2024 |
| Delaet Ingrid | Chief Regulatory O… | EXERCISE | $15K–$50K | 273 | $79.02 | Jun 4, 2024 |
| Delaet Ingrid | Chief Regulatory O… | SELL | $15K–$50K | 273 | $136.55 | Jun 4, 2024 |
| SHERWIN STEPHEN A | Director | EXERCISE | $1M+ | 40K | $44.68 | May 30, 2024 |
| SHERWIN STEPHEN A | Director | SELL | $1M+ | 40K | $133.46 | May 30, 2024 |
| BENEVICH ERIC | Chief Commercial O… | EXERCISE | $1M+ | 20K | $81.21 | Apr 17, 2024 |
| BENEVICH ERIC | Chief Commercial O… | SELL | $1M+ | 20K | $133.36 | Apr 17, 2024 |
| Delaet Ingrid | Chief Regulatory O… | EXERCISE | $15K–$50K | 272 | $79.02 | Apr 3, 2024 |
| Delaet Ingrid | Chief Regulatory O… | SELL | $15K–$50K | 272 | $137.30 | Apr 3, 2024 |
| Delaet Ingrid | Chief Regulatory O… | SELL | $500K+ | 5K | $145.06 | Mar 25, 2024 |
| Delaet Ingrid | Chief Regulatory O… | EXERCISE | $500K+ | 5K | $103.52 | Mar 25, 2024 |
| Delaet Ingrid | Chief Regulatory O… | EXERCISE | $500K+ | 7K | $79.02 | Mar 1, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 622 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| DODGE & COX | 5.5M | $1M+ | SH |
| STATE STREET CORP | 4.2M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 2.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $1M+ | SH |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 1.3M | $1M+ | SH |
| NORGES BANK | 1.1M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 851K | $1M+ | SH |
| Pictet Asset Management Holding SA | 777K | $1M+ | SH |
| BRAIDWELL LP | 752K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 634K | $1M+ | SH |
| Swedbank AB | 584K | $1M+ | SH |
| Swedbank AB | 584K | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 555K | $1M+ | SH |
| PRIMECAP MANAGEMENT CO/CA/ | 508K | $1M+ | SH |
| IEQ CAPITAL, LLC | 505K | $1M+ | SH |
| FIRST TRUST ADVISORS LP | 487K | $1M+ | SH |
| Zurich Insurance Group Ltd/FI | 459K | $1M+ | SH |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 361K | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 331K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 314K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Jan 21, 2026
5.2%
5.2M shares
SC 13G · May 14, 2025
5.6%
5.5M shares
SC 13G/A · Apr 28, 2025
12.1%
12.1M shares
SC 13G/A · Mar 6, 2025
10.2%
10.1M shares
SC 13G · Feb 5, 2025
4.8%
4.9M shares
STATE STREET CORPORATION 04-2456637
SC 13G · Oct 17, 2024
5.1%
5.1M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.9%
9.7M shares
SC 13G/A · Jan 23, 2024
13.9%
13.6M shares
SC 13G/A · Jan 23, 2023
13.1%
12.6M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
4.5%
4.4M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 10, 2022
7.8%
7.4M shares
SC 13G/A · Jan 27, 2022
12.1%
11.5M shares
SC 13G/A · Jan 25, 2022
12.1%
11.5M shares